Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Hum Brain Mapp ; 39(4): 1721-1742, 2018 04.
Article in English | MEDLINE | ID: mdl-29327392

ABSTRACT

Brain alterations are hypothesized to be present in patients with chronic whiplash-associated disorders (CWAD). The aim of this case-control study was to examine alterations in cortical thickness and white matter (WM) structure, and the presence of brain microhemorrhages in a patient group encountering chronic neck pain of traumatic origin (i.e., CWAD) when compared with a patient group characterized by nontraumatic chronic neck pain [i.e., chronic idiopathic neck pain (CINP)], and healthy controls. Furthermore, we aimed to investigate associations between brain structure on one hand and cognitive performance and central sensitization (CS) on the other hand. T1-weighted, diffusion-weighted and T2*-weighted magnetic resonance images of the brain were acquired in 105 women (31 controls, 37 CINP, 37 CWAD) to investigate regional cortical thickness, WM structure, and microhemorrhages, respectively. Next, cognitive performance, and CS encompassing distant hyperalgesia and conditioned pain modulation (CPM) efficacy were examined. Cortical thinning in the left precuneus was revealed in CWAD compared with CINP patients. Also, decreased fractional anisotropy, together with increased values of mean diffusivity and radial diffusivity could be observed in the left cingulum hippocampus and tapetum in CWAD compared with CINP, and in the left tapetum in CWAD patients compared with controls. Moreover, the extent of WM structural deficits in the left tapetum coincided with decreased CPM efficacy in the CWAD group. This yields evidence for associations between decreased endogenous pain inhibition, and the degree of regional WM deficits in CWAD. Our results emphasize the role of structural brain alterations in women with CWAD compared with CINP.


Subject(s)
Cerebral Cortex/diagnostic imaging , Chronic Pain/diagnostic imaging , Neck Pain/diagnostic imaging , Whiplash Injuries/diagnostic imaging , White Matter/diagnostic imaging , Adolescent , Adult , Case-Control Studies , Cerebral Cortex/pathology , Chronic Pain/etiology , Chronic Pain/psychology , Cognition , Cross-Sectional Studies , Female , Humans , Image Processing, Computer-Assisted , Magnetic Resonance Imaging , Middle Aged , Neck Pain/etiology , Neck Pain/psychology , Organ Size , Whiplash Injuries/complications , Whiplash Injuries/psychology , Young Adult
2.
B-ENT ; 5(3): 137-41, 2009.
Article in English | MEDLINE | ID: mdl-19902848

ABSTRACT

PROBLEMS/OBJECTIVES: To assess remission rate, treatment results, and factors for remission in patients with adult-onset recurrent respiratory papillomatosis (AORRP). METHODOLOGY: In this retrospective study, the clinical and pathological data of 51 patients with AORRP, treated in University Hospitals between 1972 and 2006 were reviewed. The male-female ratio was 7:3. At diagnosis, the median age was 43 years, and the median retrospective Coltrera-Derkay Staging and Severity score was 6 (range, 2-28). Twenty-one patients (41%) received only surgical treatment. Thirty patients (59%) were treated with surgery and adjuvant intralesional cidofovir. RESULTS: At the time of analysis in December 2006, 69% of the patients were in remission. Of those, 46% had been treated with adjuvant cidofovir. Of the patients who were not in remission, 87% had been treated with adjuvant cidofovir. This difference was statistically significant (p = 0.005). No significant difference was found between the remission group and the non-remission group for the factors age, gender, smoking habits, alcohol habits, GERD, severity and duration of therapy. CONCLUSIONS: AORRP was curable in most patients after long intensive treatment, with a general remission rate of 69%. Cidofovir was a negative factor for remission (p = 0.005). No other statistically significant factors for remission were found. Although a control group was present, it was not possible to perform a randomized study with comparable groups. A well-designed placebo-controlled, double-blinded, randomized trial to assess the outcomes of adjuvant intralesional cidofovir therapy for RRP would be valuable.


Subject(s)
Antineoplastic Agents/therapeutic use , Laryngeal Neoplasms/surgery , Papilloma/surgery , Adolescent , Adult , Age of Onset , Aged , Aged, 80 and over , Antineoplastic Agents/administration & dosage , Chemotherapy, Adjuvant , Cidofovir , Cytosine/administration & dosage , Cytosine/analogs & derivatives , Cytosine/therapeutic use , Female , Humans , Injections, Intralesional , Laryngeal Neoplasms/drug therapy , Laryngeal Neoplasms/epidemiology , Laryngoscopy , Male , Neoplasm Recurrence, Local , Organophosphonates/administration & dosage , Organophosphonates/therapeutic use , Papilloma/drug therapy , Papilloma/epidemiology , Retrospective Studies , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...